{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T08:53:30Z","timestamp":1769244810198,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroscience Methods"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.jneumeth.2006.07.010","type":"journal-article","created":{"date-parts":[[2006,8,25]],"date-time":"2006-08-25T11:43:13Z","timestamp":1156506193000},"page":"300-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Intravenous levodopa administration in humans based on a two-compartment kinetic model"],"prefix":"10.1016","volume":"159","author":[{"given":"Mollie","family":"Gordon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Markham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna M.","family":"Hartlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan M.","family":"Koller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Loftin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin J.","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneumeth.2006.07.010_bib1","first-page":"787","article-title":"Der l-3,4-dioxyphenylalanin (=DOPA)-Effekt bei Parkinson-Akinese","volume":"73","author":"Birkmayer","year":"1961","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib2","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/1531-8257(200011)15:6<1194::AID-MDS1019>3.0.CO;2-H","article-title":"Response to levodopa challenge in Tourette syndrome","volume":"15","author":"Black","year":"2000","journal-title":"Movement Disord"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1152\/jn.2000.84.1.549","article-title":"Dopamine D1 agonist activates temporal lobe structures in primates","volume":"84","author":"Black","year":"2000","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib4","first-page":"118","article-title":"Mapping and quantification of dopamine D2 receptor activation","volume":"14","author":"Black","year":"2002","journal-title":"J Neuropsychiatr Clin Neurosci"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib5","doi-asserted-by":"crossref","first-page":"17113","DOI":"10.1073\/pnas.012260599","article-title":"A possible substrate for dopamine-related changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonist","volume":"99","author":"Black","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-0270(03)00096-7","article-title":"Rapid intravenous loading of levodopa for human research: clinical results","volume":"127","author":"Black","year":"2003","journal-title":"J Neurosci Meth"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0006-8993(97)01191-8","article-title":"Effects of repeated administration of l-DOPA and apomorphine on circling behavior and striatal dopamine formation","volume":"784","author":"Brannan","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1126\/science.127.3296.471.a","article-title":"On the presence of 3-hydroxytyramine in brain","volume":"127","author":"Carlsson","year":"1958","journal-title":"Science"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1023\/B:JOPA.0000039566.75368.59","article-title":"Modeling the short- and long-duration responses to exogenous levodopa and to endogenous levodopa production in Parkinson's disease","volume":"31","author":"Chan","year":"2004","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10928-005-0039-x","article-title":"Importance of within subject variation in levodopa pharmacokinetics: a 4-year cohort study in Parkinson's disease","volume":"32","author":"Chan","year":"2005","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.bjp.0701133","article-title":"Effect of l-dopa alone and with benserazide on the spontaneous activity of striatal neurones in normal and 6-hydroxydopamine-lesioned rats","volume":"121","author":"Chang","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0730-725X(95)02100-8","article-title":"Mapping drug-induced changes in cerebral R2* by multiple gradient recaled echo functional MRI","volume":"14","author":"Chen","year":"1996","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib13","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1210\/jcem-62-3-466","article-title":"l-Dopa stimulates release of hypothalamic growth hormone-releasing hormone in humans","volume":"62","author":"Chihara","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib14","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s00415-003-0257-3","article-title":"Assessing dopaminergic function in Parkinson's disease: levodopa kinetic-dynamic modeling and SPECT","volume":"250","author":"Contin","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib15","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00007691-200112000-00005","article-title":"Levodopa therapy monitoring in patients with Parkinson disease: a kinetic-dynamic approach","volume":"23","author":"Contin","year":"2001","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib16","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1212\/WNL.44.7.1287","article-title":"Longitudinal monitoring of the levodopa concentration\u2013effect relationship in Parkinson's disease","volume":"44","author":"Contin","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib17","first-page":"1374","article-title":"A levodopa kinetic-dynamic study of the rate of progression in Parkinson's disease","volume":"53","author":"Contin","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib18","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM196702162760703","article-title":"Aromatic amino acids and modifications of parkinsonism","volume":"276","author":"Cotzias","year":"1967","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1017\/S0033291700054283","article-title":"Reliabiliy, validity, and clinical application of the visual analogue mood scale","volume":"3","author":"Folstein","year":"1973","journal-title":"Psychol Med"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0378-4347(00)84701-5","article-title":"Dihydrocaffeic acid: a common contaminant in the liquid chromatographic-electrochemical measurement of plasma catecholamines in man","volume":"311","author":"Goldstein","year":"1984","journal-title":"J Chromatogr"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2125.1986.tb02913.x","article-title":"The pharmacokinetics of intravenous and oral levodopa in patients with Parkinson's disease who exhibit on\u2013off fluctuations","volume":"22","author":"Hardie","year":"1986","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib22","doi-asserted-by":"crossref","first-page":"12016","DOI":"10.1073\/pnas.95.20.12016","article-title":"Altered thalamic response to levodopa in Parkinson's patients with dopa-induced dyskinesias","volume":"95","author":"Hershey","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib23","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/exnr.2000.7522","article-title":"Dopa-induced blood flow responses in non-human primates","volume":"166","author":"Hershey","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib24","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/jnnp.74.7.844","article-title":"Chronic treatment and disease severity alter brain responses to levodopa in PD","volume":"74","author":"Hershey","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib25","first-page":"309","article-title":"Die Topische Lokalisation und das Verhalten von Noradrenalin und Dopamin in der Substantia Nigra des normalen und Parkinsonkranken Menschen","volume":"75","author":"Hornykiewicz","year":"1963","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib26","first-page":"839","article-title":"Biochemisch-pharmakologische Grundlagen f\u00fcr die klinische Anwendung von l-dioxyphenylalanin beim Parkinson-Syndrom","volume":"73","author":"Hornykiewicz","year":"1961","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1600-0773.1999.tb02014.x","article-title":"Microdialysis studies on the action of tolcapone pharmacologically-elevated extracellular dopamine levels in conscious rats","volume":"85","author":"Huotari","year":"1999","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib28","first-page":"120","article-title":"Modified high-performance liquid chromatography with electrochemical detection method for plasma measurement of levodopa, 3-O-methyldopa, dopamine, carbidopa and 3,4-dihydroxyphenyl acetic acid","volume":"836","author":"Karimi","year":"2006","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1248\/bpb.18.13","article-title":"Effects of l-dopa on cholecystokinin octapeptide tissue levels in normal and 6-hydroxydopamine-treated rat brain","volume":"18","author":"Kimura","year":"1995","journal-title":"Biol Pharmacol Bull"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0022-510X(94)00237-I","article-title":"Levodopa-induced local cerebral blood flow changes in Parkinson's disease and related disorders","volume":"128","author":"Kobari","year":"1995","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib31","doi-asserted-by":"crossref","first-page":"464","DOI":"10.7326\/0003-4819-80-4-464","article-title":"Provocative tests of growth-hormone release. A comparison of results with seven stimuli","volume":"80","author":"Lin","year":"1974","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/BF03348770","article-title":"Secretion of growth hormone releasing hormone in obese children","volume":"15","author":"Loche","year":"1992","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib33","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1212\/WNL.33.7.950","article-title":"Chronic l-dopa administration decreases striatal accumulation of dopamine from exogenous L-dopa in rats with intact nigrostriatal projections","volume":"33","author":"Melamed","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0165-1781(01)00317-1","article-title":"Inpatient diagnostic assessments. 1. Accuracy of structured versus unstructured interviews","volume":"105","author":"Miller","year":"2001","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib35","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1212\/WNL.34.6.805","article-title":"Effortful and automatic memory: effects of dopamine","volume":"34","author":"Newman","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib36","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1212\/WNL.36.6.739","article-title":"Levodopa pharmacokinetics and pharmacodynamics in fluctuating parkinsonian patients","volume":"36","author":"Nutt","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib37","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/ana.410180505","article-title":"The effect of carbidopa on the pharmacokinetics of intravenously administered levodopa: the mechanism of action in the treatment of parkinsonism","volume":"18","author":"Nutt","year":"1985","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/mds.870120304","article-title":"Motor fluctuations during continuous levodopa infusions in patients with Parkinson's disease","volume":"12","author":"Nutt","year":"1997","journal-title":"Mov Disord"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib39","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/0014-4886(92)90203-3","article-title":"Simultaneous microdialysis in striatum and substantia nigra suggests that the nigra is a major site of action of L-dihydroxyphenylalanine in the \u201chemiparkinsonian\u201d rat","volume":"115","author":"Orosz","year":"1992","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM197201062860102","article-title":"Levodopa in parkinsonism: potentiation of central effects with a peripheral inhibitor","volume":"286","author":"Papavasiliou","year":"1972","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000298843","article-title":"Prolactin changes after administration of agonist and antagonist dopaminergic drugs in puerperal women","volume":"23","author":"Petraglia","year":"1987","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib42","first-page":"36","article-title":"Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine","volume":"84","author":"Pontiroli","year":"1977","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib43","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1073\/pnas.84.16.5995","article-title":"Local cerebral metabolic effects of l-dopa therapy in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys","volume":"84","author":"Porrino","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib44","first-page":"28","article-title":"Blocking serotonin reuptake reduces exogenous l-DOPA derived dopamine release in chemically dopamine-depleted rats","author":"Rau","year":"2002","journal-title":"Soc Neurosci Abstr"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2125.1989.tb03506.x","article-title":"The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa","volume":"28","author":"Robertson","year":"1989","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib46","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/09647049709525715","article-title":"From DOPA to Parkinson's disease: the early history of dopamine research","volume":"6","author":"Roe","year":"1997","journal-title":"J Hist Neurosci"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib47","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00005053-199506000-00003","article-title":"A comparison of the structured clinical interview for DSM-III-R and clinical diagnoses","volume":"183","author":"Steiner","year":"1995","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib48","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1212\/WNL.46.5.1430","article-title":"Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C] raclopride displacement and PET","volume":"46","author":"Tedroff","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib49","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0278-5846(95)00132-F","article-title":"D1\/D2 actions of dopaminergic drugs studied with [14C]-2-deoxyglucose autoradiography","volume":"19","author":"Trugman","year":"1995","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.jneumeth.2006.07.010_bib50","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1152\/ajplegacy.1975.228.2.352","article-title":"Rat brain regional uptake and decarboxylation of l-DOPA following carotid injection","volume":"228","author":"Wade","year":"1975","journal-title":"Am J Physiol"}],"container-title":["Journal of Neuroscience Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016502700600327X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016502700600327X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:10:30Z","timestamp":1759018230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016502700600327X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S016502700600327X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneumeth.2006.07.010","relation":{},"ISSN":["0165-0270"],"issn-type":[{"value":"0165-0270","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous levodopa administration in humans based on a two-compartment kinetic model","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroscience Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneumeth.2006.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}